STENOCARE UNHARMED BY HEALTH CANADA’S AUDIT OF CANNTRUST
All batches of products received by STENOCARE from CannTrust, but one, are unrelated to the current issue. The related batch, very small and still in stock, has been identified and is put in quarantine. This is not expected to have any negative impact on patients nor STENOCARE.Yesterday, STENOCARE’s partner in Canada, CannTrust released a Statement Regarding Health Canada Audit. Link to message: https://canntrust.com/canntrust-statement-regarding-health-canada-audit/. What is this? Unauthorized production took place in five new cultivation rooms at the CannTrust facility during